Bharat Biotech commences direct supply of Covaxin to 14 states

Bharat Biotech commences direct supply of Covaxin to 14 states

FPJ Web DeskUpdated: Monday, May 10, 2021, 12:19 PM IST
article-image
Covaxin developer Bharat Biotech to sell COVID vaccine directly to 14 states in India |

Bharat Biotech has commenced direct supply of its COVID-19 vaccine 'ovaxin to 14 states, including Delhi and Maharashtra, with effect from May 1, according to the company's Joint Managing Director Suchitra Ella.

The Hyderabad-based firm has started supplying its COVID-19 treatment vaccine to the states based on the allocations received by the central government.

"Bharat Biotech confirms direct supplies of COVAXIN to the following state govt''s since 1/5/21, based on the allocations received by GoI. Requests have been received from other states, & will be processed for distribution based on availability of stocks 24x7," Ella tweeted.

The company is supplying vaccines to Andhra Pradesh, Assam, Chhattisgarh, Gujarat, Jammu & Kashmir, Jharkhand, Madhya Pradesh, Odisha, Tamil Nadu, Telangana, Uttar Pradesh and West Bengal.

On April 29, Bharat Biotech announced a cut in the price of ''Covaxin'' for states to Rs 400 per dose from the earlier Rs 600 per dose.

This followed widespread criticism of its pricing policy as it sold Covaxin to the central government at Rs 150 per dose.

India has announced expansion of its COVID-19 vaccination drive by allowing its large 18-plus population to get inoculated from May 1.

RECENT STORIES

How Data Is Enabling Innovation In Biomedical Devices For Healthier Lives

How Data Is Enabling Innovation In Biomedical Devices For Healthier Lives

Heralding Mediated Dispute Resolution Over Litigation: The Mediation Act, 2023, Future Of Indian...

Heralding Mediated Dispute Resolution Over Litigation: The Mediation Act, 2023, Future Of Indian...

Force Motors Shifts Gears: Exiting Tractors And Connected Activity Business At The End Of FY24

Force Motors Shifts Gears: Exiting Tractors And Connected Activity Business At The End Of FY24

'From Shop Floor To Success,' Anand Mahindra Backs Elon Musk's Call For Recognition Of Manufacturing...

'From Shop Floor To Success,' Anand Mahindra Backs Elon Musk's Call For Recognition Of Manufacturing...

Bank Of India Faces ₹564 Crore Penalty From Income Tax Department; Yes Bank Also Hit With ₹113...

Bank Of India Faces ₹564 Crore Penalty From Income Tax Department; Yes Bank Also Hit With ₹113...